Clinical trials
View the clinical trials and research studies currently recruiting at the Jreissati Pancreatic Centre at Epworth.
For further information:
Phone: 03 9426 8880
Email: [email protected]
The Jreissati Pancreatic Centre at Epworth runs research studies and clinical trials covering every phase of patient diagnosis, treatment and care. The goal is to improve patient outcomes and quality of life for patients with pancreatic cancer.
Clinical trials are vital if we are to improve the survival rate for patients with pancreatic cancer. But what are they?
Types of research include:
- observational studies that collect data on a disease's trajectory to better understand it.
- interventional clinical trials to determine whether an experimental treatment is safe and effective.
The main goal of clinical trials is to see if discoveries made during the research phase are better than current treatment options.
For clinical trials, volunteer participation is essential. Results from trials will help determine if new treatments for pancreatic cancer work and if there are side effects. They're also an effective way for patients to gain access to the latest treatment options.
When deciding if you want to take part in a clinical trial, you need to be aware of what the trial involves. You should also seek advice from your specialist before taking part. At Epworth, there are a number of clinical studies open to people with pancreatic cancer and are listed below.
Pancreatic cancer research at the Jreissati Pancreatic Centre at Epworth
How do I join a clinical trial?
Your GP will need to refer you to our centre. After we receive your referral, we'll contact you by phone to schedule an appointment with a specialist within 72 hours.
During your appointment, the specialist will review your medical history and assess whether you are a suitable candidate for a clinical trial.
If you would like more information or if you have questions after your referral is submitted, contact our team.
Clinical trials currently open for recruitment
Listing updated: 25 March 2024
Current trials at the Jreissati Pancreatic Centre at Epworth
Current research studies
These studies may ask participants for permission to store their cancer sample, or take part in non-treatment research. Please get in touch using the online form, email or phone listed on the contact us page to take part in advancing research.
| Diagnosis | Study title | Summary | Locations | Contact |
| Suspected diagnosis of pancreatic cancer or cholangiocarcinoma | The Victorian Pancreatic Cancer Biobank (VPCB) |
The VPCB collects biospecimens to facilitate research focused on improving pancreatic cancer outcomes. | Epworth Richmond | Dr Peter Tagkalidis |
| Pancreatic cancer |
Molecular Screening and Therapeutics Program (MoST) |
The MoST study uses genomic technology to characterise molecular changes in a patient's cancer that may help to identify a targeted therapy. | All Epworth sites | N/A |
| Unresectable pancreatic cancer | An Observational Study following Circulating tumour DNA during multi-Agent Therapy in PDAC (OSCILLATE) | The OSCILLATE study investigates whether DNA released by tumour cells can be used to predict disease response throughout treatment. | Epworth Freemasons Epworth Richmond Epworth Eastern |
Dr Allan Zimet |
| High-risk individuals (familial or hereditary pancreatic cancer) | The Australian Pancreatic Cancer Screening Program (APCSP) | The APCSP screens and collects information from individuals at high risk of developing pancreatic cancer to improve early detection. | All Epworth sites | A/Prof Andrew Metz |
| Suspected diagnosis of pancreatic cancer | SCANPatient
|
The SCANPatient study aims to determine whether a standardised reporting template will result in more accurate diagnosis of localised pancreatic cancer to improve delivery of care. | Epworth Richmond Epworth Freemasons |
Mr Julian Choi |
Databases and registries
These projects ask participants for permission to record treatment data to build better knowledge of pancreatic cancer care. Please get in touch using the online form, email or phone details on the contact us page if you see you or your patient’s diagnosis listed below.
| Diagnosis | Project ID and status | Study details | Locations | Contact |
| Newly diagnosed upper GI cancer | EH2017-227 Recruiting |
UGICR Upper Gastrointestinal Cancer Registry |
Epworth Freemasons Epworth Richmond Epworth Eastern |
Mr Brett Knowles |
| Newly diagnosed pancreatic cancer | ACTRN12617001474347 Recruiting |
PURPLE Pancreatic cancer: Understanding Routine Practice and Lifting End Results. A Prospective Pancreatic Cancer Clinical Registry |
Epworth Freemasons Epworth Richmond Epworth Eastern |
A/Prof Rachel Wong |
| Intraductal papillary mucinous neoplasm (PPMN) | EH2021-731 Recruiting |
IPMN IPMN Database – A tool to predict pancreatic cancer |
Epworth Eastern | A/Prof Andrew Metz |
| Pancreatic cancer | EH2021-768 New study Recruiting |
PAN-ExPERT Pancreatic enzyme replacement therapy in pancreatic cancer: An implementation strategy |
Epworth Richmond | Mr Mark Cullinan |
| Pancreatic or oesophageal cancer | Recruiting | PROpatient PROpatient - A registry-based randomised controlled trial (RRCT) of symptom monitoring, using patient-reported outcomes |
All Epworth sites | Mr Brett Knowles |
Phone: 03 9426 8880
Email: [email protected]
Talk to our pancreatic nurse coordinator
Get referred